ALLERGY RELIEF ANTIHISTAMINE- diphenhydramine hydrochloride capsule, liquid filled 
CDMA Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Allergy Relief Antihistamine

Drug Facts

Active ingredient (in each softgel)

Diphenhydramine HCl 25mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
• runny nose  • itchy, watery eyes  • sneezing  • itching of the nose or throat
temporarily relieves these symptoms due to the common cold: • runny nose  • sneezing

Warnings

Do not use:
• to make a child sleepy   • with any other product containing diphenhydramine, even one used on skin

Ask a doctor before use if you have:
• 
glaucoma    • trouble urinating due to an enlarged prostate gland    • a breathing problem such as emphysema or chronic bronchitis

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers

When using this product:
• marked drowsiness may occur
• avoid alcoholic drinks
• alcohol, sedatives, and tranquilizers may increase drowsiness
• be careful when driving a motor vehicle or operating machinery
• excitability may occur, especially in children

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children

Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.

Directions

• take every 4 to 6 hours • do not take more than 6 doses in 24 hours.

adults and children 12 years of age and over  1 to 2 softgel
children 6 to under 12 years  1 softgel
children under 6 years of age  do not use this product

Other information

• store at room temperature between 20-25°C (68-77°F)   • avoid excessive heat, humidity and light

Inactive ingredients

edible white ink, gelatin, glycerin, polyethylene glycol, povidone, purified water, sorbitol sorbitan solution

Questions or Comments?

Call: 1-888-577-8033 Monday - Friday 9am-4:30pm EST

QC®
QUALITY CHOICE

*Compare to the active Ingredient in BENADRYL® Allergy LIQUI-GELS®

Dye-Free

• Relieves sneezing
• Itchy, watery eyes
• Runny nose
• Itchy throat

TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

*This product is not manufactured or distributed by McNeil Consumer Healthcare, distributor of Benadryl®,or Catalent Pharma Solutions, Inc., owner of the registered trademark LIQUI-GELS®.

QC 100% SATISFACTION GUARANTEED

Distributed by C.D.M.A., Inc.©
43157 W 9 Mile Rd
Novi, MI 48375
www.qualitychoice.com
Questions: 800-935-2362

Product of UAE

Packaged and Quality assured in USA

READ AND KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION

REV.01-092022

Packaging

CDMA-474

ALLERGY RELIEF ANTIHISTAMINE 
diphenhydramine hydrochloride capsule, liquid filled
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63868-474
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40) (DIPHENHYDRAMINE - UNII:8GTS82S83M) DIPHENHYDRAMINE HYDROCHLORIDE25 mg
Inactive Ingredients
Ingredient NameStrength
GELATIN, UNSPECIFIED (UNII: 2G86QN327L)  
GLYCERIN (UNII: PDC6A3C0OX)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
WATER (UNII: 059QF0KO0R)  
SORBITOL (UNII: 506T60A25R)  
SORBITAN (UNII: 6O92ICV9RU)  
Product Characteristics
ColorWHITE (clear) Scoreno score
ShapeCAPSULESize15mm
FlavorImprint Code 783
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63868-474-242 in 1 CARTON05/01/2021
112 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart34105/01/2021
Labeler - CDMA Inc (011920774)

Revised: 7/2023
Document Id: 7e4f2b47-6a1d-48f0-b231-f979a82e0abe
Set id: c5fdd413-912f-4f80-8376-2dd6c4eabbde
Version: 3
Effective Time: 20230725
 
CDMA Inc